Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis

World Journal of Gastroenterology

Volumn 23, Issue 33, 2017, Pages 6016-6029

  Eichele, Derrick D ^a   Kharbanda, Kusum K ^a,b  

^a NEBRASKA MEDICAL CENTER   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

Dextran sodium sulfate; Experimental colitis; Inflammatory bowel disease; Intestinal barrier; Pathogenesis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CLAUDIN 1; DEXTRAN SULFATE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; JUNCTIONAL ADHESION MOLECULE A; MUCIN; OCCLUDIN; PROBIOTIC AGENT; PROTEIN ZO1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; CYTOKINE;

ADAPTIVE IMMUNITY; BIFIDOBACTERIUM; CARD15 GENE; CROHN DISEASE; CYTOKINE RELEASE; DEXTRAN SULFATE SODIUM-INDUCED COLITIS; DISEASE ASSOCIATION; DISEASE MODEL; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS; MEDICAL RESEARCH; METABOLOME; NONHUMAN; PATHOGENESIS; PERMEABILITY BARRIER; PROTEIN EXPRESSION; REPRODUCIBILITY; REVIEW; ULCERATIVE COLITIS; ANIMAL; CHEMICALLY INDUCED; COLON; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; METABOLISM; MOUSE; PATHOLOGY; PERMEABILITY; TIME FACTOR;

ANIMALS; COLON; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES; METABOLOME; MICE; MUCINS; PERMEABILITY; PROBIOTICS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 85029187760     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v23.i33.6016     Document Type: Review

References (90)

1. Randhawa PK, Singh K, Singh N, Jaggi AS. A review on chemical-induced inflammatory bowel disease models in rodents. Korean J Physiol Pharmacol 2014; 18: 279-288 [PMID: 25177159 DOI: 10.4196/kjpp.2014.18.4.279]
2. Kiesler P, Fuss IJ, Strober W. Experimental Models of Inflammatory Bowel Diseases. Cell Mol Gastroenterol Hepatol 2015; 1: 154-170 [PMID: 26000334 DOI: 10.1016/j.jcmgh.2015.01.006]
3. Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M, Price VH, Grisham MB. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 2009; 296: G135-G146 [PMID: 19033538 DOI: 10.1152/ajpgi.90462.2008]
4. Perše M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol 2012; 2012: 718617 [PMID: 22665990 DOI: 10.1155/2012/718617]
5. Neurath M, Fuss I, Strober W. TNBS-colitis. Int Rev Immunol 2000; 19: 51-62 [PMID: 10723677]
6. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007; 2: 541-546 [PMID: 17406617 DOI: 10.1038/nprot.2007.41]
7. Wirtz S, Neurath MF. Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 2007; 59: 1073-1083 [PMID: 17825455 DOI: 10.1016/j.addr.2007.07.003]
8. Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol 2014; 104: Unit 15.25. [PMID: 24510619 DOI: 10.1002/0471142735.im1525s104]
9. Boirivant M, Fuss IJ, Chu A, Strober W. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998; 188: 1929-1939 [PMID: 9815270]
10. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009; 361: 2066-2078 [PMID: 19923578 DOI: 10.1056/NEJMra0804647]
11. Sartor RB. Mechanisms of disease: pathogenesis of Crohn' s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 390-407 [PMID: 16819502 DOI: 10.1038/ncpgasthep0528]
12. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005; 129: 827-836 [PMID: 16143122 DOI: 10.1053/j.gastro.2005.06.021]
13. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010; 107: 14691-14696 [PMID: 20679230 DOI: 10.1073/pnas.1005963107]
14. Hviid A, Svanström H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011; 60: 49-54 [PMID: 20966024 DOI: 10.1136/gut.2010.219683]
15. Wallace KL, Zheng LB, Kanazawa Y, Shih DQ. Immunopathology of inflammatory bowel disease. World J Gastroenterol 2014; 20: 6-21 [PMID: 24415853 DOI: 10.3748/wjg.v20.i1.6]
16. Abraham C, Cho JH. Functional consequences of NOD2 (CARD15) mutations. Inflamm Bowel Dis 2006; 12: 641-650 [PMID: 16804402 DOI: 10.1097/01.MIB.0000225332.83861.5f]
17. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nuñez G, Flavell RA. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307: 731-734 [PMID: 15692051 DOI: 10.1126/science.1104911]
18. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004; 99: 2393-2404 [PMID: 15571588 DOI: 10.1111/j.1572-0241.2004.40304.x]
19. Carlsson AH, Yakymenko O, Olivier I, Hakansson F, Postma E, Keita AV, Söderholm JD. Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis. Scand J Gastroenterol 2013; 48: 1136-1144 [PMID: 23971882 DOI: 10.31 09/00365521.2013.828773]
20. Fujimoto J, Kadara H, Garcia MM, Kabbout M, Behrens C, Liu DD, Lee JJ, Solis LM, Kim ES, Kalhor N, Moran C, Sharafkhaneh A, Lotan R, Wistuba II. G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer. J Thorac Oncol 2012; 7: 1747-1754 [PMID: 23154545 DOI: 10.1097/JTO.0b013e31826bb1ff]
21. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105: 16731-16736 [PMID: 18936492 DOI: 10.1073/pnas.0804812105]
22. Dicksved J, Schreiber O, Willing B, Petersson J, Rang S, Phillipson M, Holm L, Roos S. Lactobacillus reuteri maintains a functional mucosal barrier during DSS treatment despite mucus layer dysfunction. PLoS One 2012; 7: e46399 [PMID: 23029509 DOI: 10.1371/journal.pone.0046399]
23. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104: 13780-13785 [PMID: 17699621 DOI: 10.1073/pnas.0706625104]
24. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, Järnerot G, Tysk C, Jansson JK, Engstrand L. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010; 139: 1844-1854.e1 [PMID: 20816835 DOI: 10.1053/j.gastro.2010.08.049]
25. Mar JS, Nagalingam NA, Song Y, Onizawa M, Lee JW, Lynch SV. Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition. Gut Microbes 2014; 5: 494-503 [PMID: 25144681 DOI: 10.4161/gmic.32147]
26. Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, Brostoff J, Parkhill J, Dougan G, Petrovska L. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 2011; 11: 7 [PMID: 21219646 DOI: 10.1186/1471-2180-11-7]
27. Rossi O, Khan MT, Schwarzer M, Hudcovic T, Srutkova D, Duncan SH, Stolte EH, Kozakova H, Flint HJ, Samsom JN, Harmsen HJ, Wells JM. Faecalibacterium prausnitzii Strain HTF-F and Its Extracellular Polymeric Matrix Attenuate Clinical Parameters in DSS-Induced Colitis. PLoS One 2015; 10: e0123013 [PMID: 25910186 DOI: 10.1371/journal.pone.0123013]
28. Martín R, Chain F, Miquel S, Lu J, Gratadoux JJ, Sokol H, Verdu EF, Bercik P, Bermúdez-Humarán LG, Langella P. The commensal bacterium Faecalibacterium prausnitzii is protective in DNBSinduced chronic moderate and severe colitis models. Inflamm Bowel Dis 2014; 20: 417-430 [PMID: 24418903 DOI: 10.1097/01. MIB.0000440815.76627.64]
29. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Doré J. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009; 15: 1183-1189 [PMID: 19235886 DOI: 10.1002/ibd.20903]
30. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, Brown D, Stares MD, Scott P, Bergerat A, Louis P, McIntosh F, Johnstone AM, Lobley GE, Parkhill J, Flint HJ. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 2011; 5: 220-230 [PMID: 20686513 DOI: 10.1038/ismej.2010.118]
31. De Fazio L, Cavazza E, Spisni E, Strillacci A, Centanni M, Candela M, Praticò C, Campieri M, Ricci C, Valerii MC. Longitudinal analysis of inflammation and microbiota dynamics in a model of mild chronic dextran sulfate sodium-induced colitis in mice. World J Gastroenterol 2014; 20: 2051-2061 [PMID: 24587679 DOI: 10.3748/wjg.v20.i8.2051]
32. Gkouskou KK, Deligianni C, Tsatsanis C, Eliopoulos AG. The gut microbiota in mouse models of inflammatory bowel disease. Front Cell Infect Microbiol 2014; 4: 28 [PMID: 24616886 DOI: 10.3389/fcimb.2014.00028]
33. D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998; 114: 2 6 2-2 6 7 [ PMI D : 9 4 5 3 4 8 5 D O I : 1 0 . 1 0 1 6 /S0016-5085(98)70476-7]
34. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117: 514-521 [PMID: 17332878 DOI: 10.1172/JCI30587]
35. Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev 2014; 13: 3-10 [PMID: 23774107 DOI: 10.1016/j.autrev.2013.06.004]
36. Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods 2004; 50: 81-92 [PMID: 15385082 DOI: 10.1016/j.vascn.2003.12.002]
37. Gaudio E, Taddei G, Vetuschi A, Sferra R, Frieri G, Ricciardi G, Caprilli R. Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig Dis Sci 1999; 44: 1458-1475 [PMID: 10489934 DOI: 10.1023/A:1026620322859]
38. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702 [PMID: 1688816 DOI: 10.1016/0016-5085(90) 90290-H]
39. Kawada M, Arihiro A, Mizoguchi E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol 2007; 13: 5581-5593 [PMID: 17948932 DOI: 10.3748/wjg.v13.i42.5581]
40. Poritz LS, Garver KI, Green C, Fitzpatrick L, Ruggiero F, Koltun WA. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. J Surg Res 2007; 140: 12-19 [PMID: 17418867 DOI: 10.1016/j.jss.2006.07.050]
41. Kim JJ, Shajib MS, Manocha MM, Khan WI. Investigating intestinal inflammation in DSS-induced model of IBD. J Vis Exp 2012; (60): pii: 3678 [PMID: 22331082 DOI: 10.3791/3678]
42. Samak G, Chaudhry KK, Gangwar R, Narayanan D, Jaggar JH, Rao R. Calcium/Ask1/MKK7/JNK2/c-Src signalling cascade mediates disruption of intestinal epithelial tight junctions by dextran sulfate sodium. Biochem J 2015; 465: 503-515 [PMID: 25377781 DOI: 10.1042/BJ20140450]
43. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69: 238-249 [PMID: 8350599]
44. Giner E, Recio MC, Ríos JL, Giner RM. Oleuropein protects against dextran sodium sulfate-induced chronic colitis in mice. J Nat Prod 2013; 76: 1113-1120 [PMID: 23758110 DOI: 10.1021/np400175b]
45. Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003; 24: 353-362 [PMID: 12663492 DOI: 10.1093/carcin/24.3.353]
46. Snider AJ, Bialkowska AB, Ghaleb AM, Yang VW, Obeid LM, Hannun YA. Murine Model for Colitis-Associated Cancer of the Colon. Methods Mol Biol 2016; 1438: 245-254 [PMID: 27150094 DOI: 10.1007/978-1-4939-3661-8-14]
47. Tanaka T. Development of an inflammation-associated colorectal cancer model and its application for research on carcinogenesis and chemoprevention. Int J Inflam 2012; 2012: 658786 [PMID: 22518340 DOI: 10.1155/2012/658786]
48. Sussman DA, Santaolalla R, Strobel S, Dheer R, Abreu MT. Cancer in inflammatory bowel disease: lessons from animal models. Curr Opin Gastroenterol 2012; 28: 327-333 [PMID: 22614440 DOI: 10.1097/MOG.0b013e328354cc36]
49. Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin LS, Centola M, Li X. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis 2009; 15: 341-352 [PMID: 18942757 DOI: 10.1002/ibd.20753]
50. Johansson ME, Sjövall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 2013; 10: 352-361 [PMID: 23478383 DOI: 10.1038/nrgastro.2013.35]
51. Low D, Nguyen DD, Mizoguchi E. Animal models of ulcerative colitis and their application in drug research. Drug Des Devel Ther 2013; 7: 1341-1357 [PMID: 24250223 DOI: 10.2147/DDDT. S40107]
52. Johansson ME, Gustafsson JK, Holmén-Larsson J, Jabbar KS, Xia L, Xu H, Ghishan FK, Carvalho FA, Gewirtz AT, Sjövall H, Hansson GC. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 2014; 63: 281-291 [PMID: 23426893 DOI: 10.1136/gutjnl-2012-303207]
53. Morgan ME, Zheng B, Koelink PJ, van de Kant HJ, Haazen LC, van Roest M, Garssen J, Folkerts G, Kraneveld AD. New perspective on dextran sodium sulfate colitis: antigen-specific T cell development during intestinal inflammation. PLoS One 2013; 8: e69936 [PMID: 23936123 DOI: 10.1371/journal.pone.0069936]
54. Iwaya H, Maeta K, Hara H, Ishizuka S. Mucosal permeability is an intrinsic factor in susceptibility to dextran sulfate sodiuminduced colitis in rats. Exp Biol Med (Maywood) 2012; 237: 451-460 [PMID: 22522346 DOI: 10.1258/ebm.2011.011269]
55. Kyoko OO, Kono H, Ishimaru K, Miyake K, Kubota T, Ogawa H, Okumura K, Shibata S, Nakao A. Expressions of tight junction proteins Occludin and Claudin-1 are under the circadian control inthe mouse large intestine: implications in intestinal permeability and susceptibility to colitis. PLoS One 2014; 9: e98016 [PMID: 24845399 DOI: 10.1371/journal.pone.0098016]
56. Luettig J, Rosenthal R, Barmeyer C, Schulzke JD. Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation. Tissue Barriers 2015; 3: e977176 [PMID: 25838982 DOI: 10.4161/21688 370.2014.977176]
57. Kitajima S, Takuma S, Morimoto M. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim 1999; 48: 137-143 [PMID: 10480018 DOI: 10.1538/expanim.48.137]
58. Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, Senninger N, Bruewer M. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 2009; 296: G1140-G1149 [PMID: 19221015 DOI: 10.1152/ajpgi.90534.2008]
59. Mähler M, Bristol IJ, Leiter EH, Workman AE, Birkenmeier EH, Elson CO, Sundberg JP. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol 1998; 274: G544-G551 [PMID: 9530156]
60. Yuan B, Zhou S, Lu Y, Liu J, Jin X, Wan H, Wang F. Changes in the Expression and Distribution of Claudins, Increased Epithelial Apoptosis, and a Mannan-Binding Lectin-Associated Immune Response Lead to Barrier Dysfunction in Dextran Sodium Sulfate-Induced Rat Colitis. Gut Liver 2015; 9: 734-740 [PMID: 25717051 DOI: 10.5009/gnl14155]
61. Tsukita S, Furuse M. Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol 1999; 9: 268-273 [PMID: 10370242 DOI: 10.1016/S0962-8924(99)01578-0]
62. Ahmad R, Chaturvedi R, Olivares-Villagómez D, Habib T, Asim M, Shivesh P, Polk DB, Wilson KT, Washington MK, Van Kaer L, Dhawan P, Singh AB. Targeted colonic claudin-2 expression renders resistance to epithelial injury, induces immune suppression, and protects from colitis. Mucosal Immunol 2014; 7: 1340-1353 [PMID: 24670427 DOI: 10.1038/mi.2014.21]
63. Grill JI, Neumann J, Hiltwein F, Kolligs FT, Schneider MR. Intestinal E-cadherin Deficiency Aggravates Dextran Sodium Sulfate-Induced Colitis. Dig Dis Sci 2015; 60: 895-902 [PMID: 25634675 DOI: 10.1007/s10620-015-3551-x]
64. Petersson J, Schreiber O, Hansson GC, Gendler SJ, Velcich A, Lundberg JO, Roos S, Holm L, Phillipson M. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 2011; 300: G327-G333 [PMID: 21109593 DOI: 10.1152/ajpgi.00422.2010]
65. Das S, Rachagani S, Sheinin Y, Smith LM, Gurumurthy CB, Roy HK, Batra SK. Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer. Oncogene 2016; 35: 2645-2654 [PMID: 26364605 DOI: 10.1038/onc.2015.327]
66. Einerhand AW, Renes IB, Makkink MK, van der Sluis M, Büller HA, Dekker J. Role of mucins in inflammatory bowel disease: important lessons from experimental models. Eur J Gastroenterol Hepatol 2002; 14: 757-765 [PMID: 12169985 DOI: 10.1097/0004 2737-200207000-00008]
67. Sheng YH, Hasnain SZ, Florin TH, McGuckin MA. Mucins in inflammatory bowel diseases and colorectal cancer. J Gastroenterol Hepatol 2012; 27: 28-38 [PMID: 21913981 DOI: 10.1111/j.1440-1746.2011.06909.x]
68. Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, Büller HA, Dekker J, Van Seuningen I, Renes IB, Einerhand AW. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006; 131: 117-129 [PMID: 16831596 DOI: 10.1053/j.gastro.2006.04.020]
69. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 2008; 105: 15064-15069 [PMID: 18806221 DOI: 10.1073/pnas.0803124105]
70. Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S, Kucherlapati R, Lipkin M, Yang K, Augenlicht L. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002; 295: 1726-1729 [PMID: 11872843 DOI: 10.1126/science.1069094]
71. Fu J, Wei B, Wen T, Johansson ME, Liu X, Bradford E, Thomsson KA, McGee S, Mansour L, Tong M, McDaniel JM, Sferra TJ, Turner JR, Chen H, Hansson GC, Braun J, Xia L. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. J Clin Invest 2011; 121: 1657-1666 [PMID: 21383503 DOI: 10.1172/JCI45538]
72. Heazlewood CK, Cook MC, Eri R, Price GR, Tauro SB, Taupin D, Thornton DJ, Png CW, Crockford TL, Cornall RJ, Adams R, Kato M, Nelms KA, Hong NA, Florin TH, Goodnow CC, McGuckin MA. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med 2008; 5: e54 [PMID: 18318598 DOI: 10.1371/journal.pmed.0050054]
73. Hoebler C, Gaudier E, De Coppet P, Rival M, Cherbut C. MUC genes are differently expressed during onset and maintenance of inflammation in dextran sodium sulfate-treated mice. Dig Dis Sci 2006; 51: 381-389 [PMID: 16534686 DOI: 10.1007/s10620-006-3142-y]
74. Brinkman BM, Becker A, Ayiseh RB, Hildebrand F, Raes J, Huys G, Vandenabeele P. Gut microbiota affects sensitivity to acute DSS-induced colitis independently of host genotype. Inflamm Bowel Dis 2013; 19: 2560-2567 [PMID: 24105395 DOI: 10.1097/MIB.0b013e3182a8759a]
75. Nagalingam NA, Kao JY, Young VB. Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis 2011; 17: 917-926 [PMID: 21391286 DOI: 10.1002/ibd.21462]
76. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002; 20: 495-549 [PMID: 11861611 DOI: 10.1146/annurev. immunol.20.100301.064816]
77. Deplancke B, Finster K, Graham WV, Collier CT, Thurmond JE, Gaskins HR. Gastrointestinal and microbial responses to sulfatesupplemented drinking water in mice. Exp Biol Med (Maywood) 2003; 228: 424-433 [PMID: 12671187 DOI: 10.1177/1535370203 22800413]
78. Hakansson A, Tormo-Badia N, Baridi A, Xu J, Molin G, Hagslätt ML, Karlsson C, Jeppsson B, Cilio CM, Ahrné S. Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice. Clin Exp Med 2015; 15: 107-120 [PMID: 24414342 DOI: 10.1007/s10238-013-0270-5]
79. Rath HC, Schultz M, Freitag R, Dieleman LA, Li F, Linde HJ, Schölmerich J, Sartor RB. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun 2001; 69: 2277-2285 [PMID: 11254584 DOI: 10.1128/IAI.69.4.2277-2285.2001]
80. Ito R, Kita M, Shin-Ya M, Kishida T, Urano A, Takada R, Sakagami J, Imanishi J, Iwakura Y, Okanoue T, Yoshikawa T, Kataoka K, Mazda O. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun 2008; 377: 12-16 [PMID: 18796297 DOI: 10.1016/j.bbrc.2008.09.019]
81. Yan Y, Kolachala V, Dalmasso G, Nguyen H, Laroui H, Sitaraman SV, Merlin D. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One 2009; 4: e6073 [PMID: 19562033 DOI: 10.1371/journal.pone.0006073]
82. Grimm V, Radulovic K, Riedel CU. Colonization of C57BL/6 Mice by a Potential Probiotic Bifidobacterium bifidum Strain under Germ-Free and Specific Pathogen-Free Conditions and during Experimental Colitis. PLoS One 2015; 10: e0139935 [PMID: 26439388 DOI: 10.1371/journal.pone.0139935]
83. Srutkova D, Schwarzer M, Hudcovic T, Zakostelska Z, Drab V, Spanova A, Rittich B, Kozakova H, Schabussova I. Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner. PLoS One 2015; 10: e0134050 [PMID: 26218526 DOI: 10.1371/journal.pone.0134050]
84. Gong Y, Li H, Li Y. Effects of Bacillus subtilis on Epithelial Tight Junctions of Mice with Inflammatory Bowel Disease. J Interferon Cytokine Res 2016; 36: 75-85 [PMID: 26720180 DOI: 10.1089/jir.2015.0030]
85. Matsunaga H, Hokari R, Kurihara C, Okada Y, Takebayashi K, Okudaira K, Watanabe C, Komoto S, Nakamura M, Tsuzuki Y, Kawaguchi A, Nagao S, Itoh K, Miura S. Omega-3 fatty acids exacerbate DSS-induced colitis through decreased adiponectin in colonic subepithelial myofibroblasts. Inflamm Bowel Dis 2008; 14: 1348-1357 [PMID: 18484673 DOI: 10.1002/ibd.20491]
86. Stenman LK, Holma R, Forsgard R, Gylling H, Korpela R. Higher fecal bile acid hydrophobicity is associated with exacerbation of dextran sodium sulfate colitis in mice. J Nutr 2013; 143: 1691-1697 [PMID: 24047703 DOI: 10.3945/jn.113.180810]
87. Araki Y, Andoh A, Tsujikawa T, Fujiyama Y, Bamba T. Alterations in intestinal microflora, faecal bile acids and short chain fatty acids in dextran sulphate sodium-induced experimental acute colitis in rats. Eur J Gastroenterol Hepatol 2001; 13: 107-112 [PMID: 11246608 DOI: 10.1097/00042737-200102000-00004]
88. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. Dietary-fatinduced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice. Nature 2012; 487: 104-108 [PMID: 22722865 DOI: 10.1038/nature11225]
89. Cipriani S, Mencarelli A, Chini MG, Distrutti E, Renga B, Bifulco G, Baldelli F, Donini A, Fiorucci S. The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PLoS One 2011; 6: e25637 [PMID: 22046243 DOI: 10.1371/journal.pone.0025637]
90. Ahmad MS, Krishnan S, Ramakrishna BS, Mathan M, Pulimood AB, Murthy SN. Butyrate and glucose metabolism by colonocytes in experimental colitis in mice. Gut 2000; 46: 493-499 [PMID: 10716678 DOI: 10.1136/gut.46.4.493]